— Know what they know.
Not Investment Advice

ENZC OTC

Enzolytics Inc.
1W: -20.0% 1M: -33.3% 3M: -55.6% YTD: +33.3% 1Y: +100.0% 3Y: -99.0% 5Y: -99.7%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±46.8%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 44 · $1.9M mcap · 4.74B float · 0.144% daily turnover · Short 20% of daily vol

Income Trends

Revenue
$0 -100.0% ▼
Gross Profit
-$22K -171.9% ▼
Operating Income
-$357K +83.4% ▲
Net Income
-$394K +81.9% ▲
EPS (Diluted)
$-0.00 +57.1% ▲
EBITDA
-$335K +84.2% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$0$200K$0$53K$0
YoY Growth+0.0%+0.0%-100.0%+0.0%-100.0%
Cost of Revenue$17K$17K$22K$22K$22K
Gross Profit-$17K$183K-$22K$31K-$22K
Gross Margin—91.5%—58.2%—
R&D Expenses$502K$117K$568K$172K$0
SG&A Expenses$3M$1M$2M$2M$335K
Operating Expenses$3M$2M$3M$2M$335K
Operating Income-$3M-$1M-$3M-$2M-$357K
Operating Margin—-705.5%—-4070.0%—
Interest Expense$177K$37K$37K$28K$37K
Income Before Tax-$3M-$669K-$3M-$2M-$394K
Tax Expense$0$0$0$0$0
Net Income-$3M-$669K-$3M-$2M-$394K
Net Margin—-334.5%—-4123.1%—
EPS (Diluted)$-0.00$-0.00$-0.00$-0.00$-0.00
EBITDA-$3M-$612K-$3M-$2M-$335K
Shares Outstanding959M2.80B2.82B2.93B1.29B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms